Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Exchange Rate Effect: 2020-2025

Historic Exchange Rate Effect for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Sep 2025 value amounting to -$8,000.

  • Maravai Lifesciences Holdings' Exchange Rate Effect was N/A to -$8,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$179,000, marking a year-over-year change of. This contributed to the annual value of -$88,000 for FY2021, which is 617.65% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Exchange Rate Effect stood at -$8,000, which was up 92.79% from -$111,000 recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Exchange Rate Effect peaked at $73,000 during Q1 2025, and registered a low of -$133,000 during Q4 2021.
  • In the last 1 years, Maravai Lifesciences Holdings' Exchange Rate Effect had a median value of -$8,000 in 2025 and averaged -$15,333.
  • Data for Maravai Lifesciences Holdings' Exchange Rate Effect shows a peak YoY increase of 109.72% (in 2021) and a maximum YoY decrease of 377.08% (in 2021) over the last 5 years.
  • Quarterly analysis of 2 years shows Maravai Lifesciences Holdings' Exchange Rate Effect stood at -$133,000 in 2021, then followed by -$8,000 in 2025.
  • Its Exchange Rate Effect stands at -$8,000 for Q3 2025, versus -$111,000 for Q2 2025 and $73,000 for Q1 2025.